Results - Announcements
3B Blackbio DX Ltd share price inched up 2.79% to Rs 1341.55 after the company's net profit saw a strong growth of 100.67% to Rs 18.02 crore, while revenue from operations gained significantly 44.16% to Rs 48.28 crore in Q2FY27 over Q2FY26.
The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 83757.59 crore, rising by 12.38%. It has improved by 0.77% over last one week and softened by 2.11% in last one month while the market capitalization of 3B Blackbio DX Ltd has marginally improved by 4.01% and 14.28% in the same period respectively.
Profit before tax (PBT) of 3B Blackbio DX Ltd stood at Rs 24.3 crore in Q2 FY27, jumping 23.85% year-on-year, and expanding by 83.81% quarter-on-quarter. EBITDA came in at Rs 16 crore, rallying 77.33% YoY and surging by 586.97% sequentially.
Total expenses grew marginally by 8.82% to Rs 28.63 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 11.07 crore, witnessing a sharp rise of 41.02% YoY, while employee benefits expense was at Rs 7.83 crore, contracting 8.42% YoY.
For FY26, revenue from operations witnessed a strong growth of 30.15% to Rs 96.47 crore, while net profit jumped 48.57% to Rs 47.69 crore, compared to previous FY. EBITDA surged by 1948% to Rs 35.03 crore, and PBT soared 44.37% to Rs 64.0 crore compared to previous FY.
The company's consolidated net cash flow from operating activities stood at Rs 43.36 crore in FY26, as against Rs 26.95 crore in FY25.
3B Blackbio DX Ltd ticked higher by 0.48% in last one year, outperforming the benchmark BSE Sensex which has slipped by 3.42% during the same period.